Serum uric acid as a new player in the development of diabetic nephropathy

Journal of Renal Nutrition

Volumn 21, Issue 1, 2011, Pages 124-127

  Hovind, Peter ^a,b   Rossing, Peter ^b   Johnson, Richard J ^c   Parving, Hans Henrik ^d,e  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c UNIVERSITY OF COLORADO   (United States)

^d Rigshospitalet   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIMETABOLITE; URIC ACID;

ANIMAL; BLOOD; DIABETIC NEPHROPATHY; DISEASE MODEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; RAT; REVIEW;

ALLOPURINOL; ANIMALS; ANTIMETABOLITES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; HUMANS; RATS; URIC ACID;

ANIMALIA; RATTUS;

EID: 78650686769     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.10.024     Document Type: Review

References (21)

1. United States Renal Data System. Available at: 2008. http://www.usrds.org.
2. Parving H.-H., Mauer M., Ritz E. Diabetic nephropathy. Brenner & Rector's The Kidney 2008, 1265-1298. WB Saunders, Boston, MA. 8th ed. B.M. Brenner (Ed.).
3. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
4. Kang D.H., Nakagawa T., Feng L., et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002, 13:2888-2897.
5. Khosla U.M., Zharikov S., Finch J.L., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
6. Sanchez-Lozada L.G., Soto V., Tapia E., et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008, 295:F1134-F1141.
7. Mazzali M., Kanellis J., Han L., et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002, 282:F991-F997.
8. Kosugi T., Nakayama T., Heinig M., et al. Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol 2009, 297:F481-F488.
9. Perlstein T.S., Gumieniak O., Hopkins P.N., et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int 2004, 66:1465-1470.
10. Mene P., Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease?. J Hypertens 2008, 26:2085-2092.
11. Obermayr R.P., Temml C., Gutjahr G., et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008, 19:2407-2413.
12. Weiner D.E., Tighiouart H., Elsayed E.F., et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008, 19:1204-1211.
13. Hovind P., Rossing P., Tarnow L., et al. Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 2009, 58:1668-1671.
14. Jalal D.I., Rivard C.J., Johnson R.J., et al. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the coronary artery calcification in type 1 diabetes study. Nephrol Dial Transplant 2010, 25:1865-1869.
15. Rosolowsky E.T., Ficociello L.H., Maselli N.J., et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol 2008, 3:706-713.
16. Ficociello LH, Rosolowsky ET, Niewczas MA, et al: High-normal serum uric acid increases risk of early declining renal function in type 1 diabetes: results of 6-year follow-up. Diabetes Care (in press).
17. Hayashi T., Babazono T., Nyumura I., et al. Serum uric acid levels and progression of CKD in diabetic patients. J Am Soc Nephrol 2008, 19:339A.
18. Feig D.I., Soletsky B., Johnson R.J. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008, 300:924-932.
19. Siu Y.P., Leung K.T., Tong M.K., et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006, 47:51-59.
20. Momeni A., Shahidi S., Seirafian S., et al. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis 2010, 4:128-132.
21. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989, 32:219-226.